Delivery Order SPE2DB25D3012-SPE2DB25FXALJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $11,498.68. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and is scheduled for completion by August 21, 2025. The award supports pharmaceutical procurement for federal medical needs, with performance occurring at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $36,207.20. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) valued at $9,341.40 under a firm fixed-price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-competed delivery order. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Carvedilol ER 40 mg capsules in quantities of 30 per unit, with a contract ceiling value of $2,692.51. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $92,216.34. This is a non-set-aside, competitively awarded delivery order with a completion date of September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on September 17, 2025, with a contract ceiling value of $14,041.92 and ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical delivery under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for Carvedilol ER 40 mg capsules (30-count bottles) with a ceiling value of $2,008.65. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement. The order is due for ultimate completion on July 16, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $50,589.89 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $84,403.33. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $2,493.78. This competitive award, made on June 30, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 1, 2025. The pharmaceutical product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement,...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXALJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $5,576.57. This competitive, firm fixed-price delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, indicating it was awarded through open competition. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems worldwide. The firm's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, positioning it as a key provider within the Defense Health Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/24/25 |